Cargando…
Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing
Since September 2010, over 10,000 patients have undergone preemptive, panel-based pharmacogenomic testing through the Vanderbilt Pharmacogenomic Resource for Enhanced Decisions in Care and Treatment (PREDICT) program. Analysis of the genetic data from the first 9,589 individuals reveals the frequenc...
Autores principales: | Van Driest, Sara L., Shi, Yaping, Bowton, Erica A., Schildcrout, Jonathan S., Peterson, Josh F., Pulley, Jill, Denny, Josh C., Roden, Dan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961508/ https://www.ncbi.nlm.nih.gov/pubmed/24253661 http://dx.doi.org/10.1038/clpt.2013.229 |
Ejemplares similares
-
Attitudes of Clinicians Following Large-Scale Pharmacogenomics Implementation
por: Peterson, Josh F., et al.
Publicado: (2015) -
A Decision-Theoretic Approach to Panel-Based, Preemptive
Genotyping
por: Shi, Yaping, et al.
Publicado: (2019) -
£10,000 swap?
por: Adam, M.
Publicado: (2021) -
Patients Pay £10,000
Publicado: (1921) -
£10,000 for Portsmouth Hospital
Publicado: (1921)